| 1 |
34581430 | Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity. | 2021 Oct 8 |
3 |
| 2 |
34876147 | Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume. | 2021 Dec 7 |
1 |
| 3 |
31442298 | Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers. | 2020 Feb |
2 |
| 4 |
31957972 | Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study. | 2020 Feb |
2 |
| 5 |
31351022 | Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome. | 2019 Dec |
2 |
| 6 |
29329963 | Switch to Ticagrelor in critical limb ischemia antiplatelet study (STT-CLIPS). | 2018 Apr - May |
1 |
| 7 |
28653184 | Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue. | 2017 Nov |
2 |
| 8 |
27628615 | Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite? The HARMONIC study. | 2016 Nov 30 |
1 |
| 9 |
25516485 | A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI. | 2014 Dec 16 |
1 |